Home › Kidney Stones › NCT04669886

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adults that is able to consent (≥ 18 years of age)
* Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals
* not currently immunosuppressed \[White blood count (WBC) \>= 2, not on immunosuppressive medications\]

Exclusion Criteria:

* unable to consent and \< 18 years of age
* currently immunosuppressed (WBC \< 2, not on immunosuppressive medications)

About the study

The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.

Sponsor: University of Miami · Participants: 150 · Started: Nov 1, 2023

Contact the study team

• Hemendra N Shah · Phone: 3052433246

Official record on ClinicalTrials.gov — NCT04669886

Locations in the U.S.

Conditions

• Kidney Stones
• Fever

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.